Diagnostic Chain of the Year (North)

Molecular Diagnostics and Therapy is delighted to have been awarded the prestigious “Diagnostic Chain of the Year – North” award at the ET Health Healthcare Awards 2026. In recognition of this, we continue to strive to advance diagnostic healthcare through innovation, advanced technology, clinical expertise, and a commitment to patient care.

Diagnostic health care is an important component of the early identification, assessment, and treatment of a range of health conditions. Throughout the years at Molecular Diagnostics and Therapy, our dedicated, professionally focused service has always been driven by the same goal: to place advanced diagnostic and nuclear medicine services in harmony with the latest advancements in imaging technologies and expertise, to help doctors and patients along their path of healthcare.

This award showcases not only our commitment to always upholding high standards of diagnostic excellence but also our ongoing efforts to have advanced healthcare services available to our communities. At every turn, our focus on technology, quality, patient experience, and continuous improvement is what guides us. This recognition was awarded to us by the prestigious ET Health Healthcare Awards 2026, in the presence of Mr. Sonam Wangchuk.

The dedication and support of our doctors and healthcare/diagnostic professionals, technologists, and our whole team, as well as our patients, referring physicians, and healthcare partners, were essential in making this recognition possible. This is a tremendous accomplishment, and we continue to establish ourselves as leaders in diagnostic health services that focus on innovation, reliability, and services that put the patient first for many years to come.